Introduction
The hippocampus is part of the limbic system and plays an important role in learning and memory, emotion, and mood. In addition, the subgranular zone in the dentate gyrus (DG) is an important site of ongoing neurogenesis throughout the lifespan of humans and other mammals [1] . Many central nervous system (CNS) disorders such as neuropsychiatric diseases (depression, anxiety disorders, and schizophrenia), neurodegenerative dis-eases (Alzheimer's disease, Parkinson's disease), and epilepsy are thought to be associated with abnormalities of the hippocampus [2] .
The development of the CNS requires the coordination of cell proliferation, migration, differentiation, synaptogenesis and apoptosis. Cell proliferation is regulated by distinct genetic programs and responses to extracellular cues such as growth factors and neurotransmitters [3, 4] . Recent evidence has highlighted the importance of glutamate, a major excitatory neurotransmitter in the mammalian CNS, in neural progenitor proliferation, neuronal migration, survival, differentiation, and synaptic plasticity in the prenatal, postnatal, and adult CNS after injury or disease [5] .
Glutamate acts on specialized ionotropic and me- as proliferation, differentiation, and the survival of neural progenitors [6] . mGluR5, a group I metabotropic glutamate receptor, is the predominant subtype expressed in zones of active neurogenesis in the prenatal and postnatal rat brain [7] and in cultured neurospheres from mouse forebrain [8] . Cell proliferation is decreased by pharmacological blockade of mGluR5 and increased by its activation. The numbers of proliferating neural progenitors are significantly reduced in the hippocampal subventricular zone (SVZ) and DG in adult mice lacking mGluR5 or treated with an mGluR5 antagonist [9, 10] . In particular, the study by Castiglione suggested that mGluR5 specifically supports the survival of progenitors undergoing differentiation into neurons [8] .
In the adult animal and human brains, many neurons in the hippocampus, cerebral cortex and corpus striatum express mGluR5, which is associated with synaptic transmission [11] . In addition, mGluR5 is also expressed by other cell-types in the brain, such as astrocytes and microglia [12] [13] [14] . It is unclear whether these cells express mGluR5
in human hippocampal development, especially in the late period before birth.
Although some animal studies have investigated the expression of mGluR5 and its co-localization with neural stem/precursor cells in the developing hippocampus, little is known about its expression and cellular distribution during human hippocampal development, especially the relationship between mGluR5 and neural progenitors. In the present study, we aimed to (1) monitor mGluR5 mRNA and protein expression in the hippocampus of the human fetus;
and (2) determine the cellular distribution of mGluR5. crown-rump length. Finally, 34 brains with no obvious abnormality were used. The samples were divided into four groups according to gestational age: 9-11 (n = 9), [14] [15] [16] (n = 10), 22-24 (n = 9) and 32-36 weeks (n = 6). Adult cerebral cortex (positive control for mGluR5 protein detection with Western blot) and cerebellum (negative control for mGluR5 protein detection with Western blot) were obtained at autopsy from four controls without a history of neurological disease. The interval between death and tissue fixation was usually <12 h. 
Materials and methods

Human brain samples
Tissue preparation
Western blot Western blot analysis of mGluR5 in
protein extracts from brain prepared according to Romano [15] was carried out as described previously [16] . Briefly, 20 µg protein per lane was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (8% polyacrylamide gels). The gel was blotted onto a nitrocellulose membrane, which was then incubated with 10% nonfat powdered milk dissolved in Tris-buffered saline with Tween 20 (TBST) for 1 h to block nonspecific binding sites, incubated overnight with primary polyclonal antibody (see Table 2 ), washed extensively with TBST, incubated for Photomicrographs were taken under an Olympus BX51 microscope equipped with a Spot camera (DP71). In the negative control, primary antibodies were replaced by PBS.
Double-labeling immunofluorescence microscopy
Double-labeling immunofluorescence microscopy was car- was considered to be statistically significant. (Fig. 1A) . The difference in mGluR5 expression between gestational 11 and 36 weeks was significant (P <0.05). In all groups, real-time PCR showed a significant increase in mGluR5 mRNA expression from 11 to 32 weeks (Fig. 1B) . On Western blots, the mGluR5 protein level also increased significantly (Fig.   1A) , apparently in parallel with the mRNA level.
Distribution of mGluR5 protein during human
hippocampal development In the sections negative for mGluR5 immunostaining, there were no immuno-positive cells. However, cells in the subplate, hippocampal plate (HP), and inner marginal zone (IMZ) were strongly immunostained for mGluR5 at 11 weeks ( Fig. 2A, a) , At 16 weeks (Fig. 2B, b) , mGluR5 showed strong expression in the IZ, subplate, HP, and IMZ, and weak expression in the ventricular zone (VZ). In all layers, mGluR5 immunoreactivity, especially in the IZ, was significantly higher than at 11 weeks (Fig. 2E) . At 24 weeks (Fig.   2C , c), mGluR5 immunoreactivity was detectable in CA1
and CA3 [stratum oriens (SO) and stratum pyramidale (SP)] but almost undetectable in CA3 [stratum radiatum (SR) [17] , stratum lacunosum-moleculare (SLM)] and the DG. At 32 weeks (Fig. 2D, d ), compared with 24 weeks, mGluR5 immunostaining decreased in CA3 SO, remained unchanged in CA3 (SR, SLM), and increased in CA1 SP (3.42 times the level at 24 weeks) and DG. At the same time, mGluR5
became apparent in the granule cell layer in the DG.
Co-localization of mGluR5 with nestin, DCX, NeuN
and GFAP In the negative control sections for mGluR5, nestin, DCX, NeuN and GFAP, there was no detectable fluorescence. At 11 weeks, mGluR5-nestin double-labeled Fig. 3D-I ; Table   3 ). About 78% of the nestin-positive cells and 75% of the mGluR5-positive cells were double-labeled (Table 3) (Fig. 3M-O) . Notably, double-labeled cells decreased in number over time (Table 3) . mGluR5 was co-localized with DCX at 11 weeks, and double-labeled cells were mainly in the HP, IZ and IMZ ( Fig. 4A-C) . Surprisingly, at 16, 24, and 32 weeks, no double-labeled cells were detectable, although antibodies from two companies were used (Fig. 4D-F) .
In order to investigate whether neurons express mGluR5 in the developing human hippocampus, we carried out a double-labeling experiment for mGluR5 and NeuN (a marker of mature neurons). Cells double-labeled for mGluR5 and NeuN were first detected in the HP at 24
weeks and increased in number at 32 weeks. They were mainly located in the SP of CA1 and the granular cell layer of the DG (Fig. 4G-I) . Moreover, the double-labeled cells appeared in the HP in an "inside-out" pattern. As for astrocytes, a few cells double-labeled for mGluR5 and GFAP were mainly found in the VZ and SVZ, while they were not detected in regions such as the hippocampal fimbria where astrocytes are known to be concentrated (Fig. 4J-L) . 16 weeks 75 ± 3* 78 ± 3* 1538 ± 143* 24 weeks 70 ± 3 60 ± 2* 651 ± 94** 32 weeks 37 ± 1 (CA1)** 53 ± 1 (CA1) 32 ± 4 (CA1)** 78 ± 2 (DG) 28 ± 1 (DG) 461 ± 37 (DG) *P <0.05, **P <0.01 versus the next younger group. The data from CA1 at 32 weeks were compared with those at 24 weeks. DG, dentate gyrus. 
Discussion
Our main findings were that (1) both mGluR5 mRNA expression and protein levels in the hippocampus increased gradually over time; and (2) the expression of mGluR5 by neural stem/progenitor cells, neuroblasts and neurons im- plied their participation in the regulation of neurogenesis in the developing human hippocampus.
mGluR5 expression in the fetal hippocampus
mGluR5 mRNA and protein are present in the fetal hippocampus of animals. In mice, mGluR5 mRNA is detectable at E15 and protein at E18, and increases perinatally, reaching a peak in the second postnatal week and decreasing thereafter [9, 15] . The profile of mGluR5 protein expression in rats is similar to that in mice. During development, mGluR5a declines while mGluR5b rises to predominate in adulthood [18, 19] . At the microscopic level, mGluR5 is seen mainly in unmyelinated axons and pyramidal cell dendrites in the first two postnatal weeks [18, 20] , but later its presence on unmyelinated axons is markedly reduced and the receptor becomes more widely distributed on dendritic spines [18, 20] .
It is known that mGluR5 is expressed in neurons of adult human hippocampus, but whether it is also expressed in the prenatal hippocampus was unknown. Here, we dem- [7] . In zone in adult rats [21] , and mGluR5-knockout mice have an almost normal hippocampus after birth [22] . Furthermore, in all stages we studied, some mGluR5-negative neural stem/ progenitor cells were always present. So we speculate that mGluR5 plays a partial and stage-specific role in neural stem cell proliferation, differentiation, and survival.
Cells positive for both mGluR5 and DCX were frequently found in the HP and IMZ at 11 weeks, but rarely thereafter. In the middle and late stages of prenatal development, hippocampal neuroblasts expressed hardly any mGluR5, suggesting that it has little effect on migrating and differentiating neuroblasts. Although neurons undergoing maturation in the hippocampus strongly express mGluR5, its expression may decline or cease before neuronal maturation.
A growing body of studies shows that mGluR5 is involved in regulating neurogenesis. This role appears to be complex, in that regulation differs in different germinal zones. In vivo and in vitro studies show that mGluR5-mediated effects on striatal neuronal progenitors are restricted mainly to early cycling populations in the VZ, with little effect on secondary proliferative populations in the SVZ. In contrast to its proliferative effects in the ventral telencephalon, mGluR5 has no such effects on dorsal telencephalon-derived cortical neuroblasts [23] . Studies in our laboratory showed that mGluR5 enhances the proliferation of neural stem cells from human fetal brain along with activation of the mitogen-activated protein kinase (MAPK) signaling pathway [24] .
It is widely believed that mGluR5 in mature neurons takes part in synaptogenesis, synaptic plasticity and synaptic transmission. In addition, mGluR5 can be expressed by mature astrocytes, microglia and oligodendroglia. How-ever, López-Bendito et al. did not find any cells doublelabeled with mGluR5 and GFAP in fetal rat brain [18] . We found no cells double-labeled with mGluR5 and GFAP in the developing hippocampus.
This study has some limitations, such as the small sample size and variance in genetic background and quality. But these limitations do not influence the conclusion Therefore, mGluR5 mainly regulates the proliferation of neural stem/progenitor cells with MAPK pathway in early development [24] . However, in late development, it mainly takes part in the synaptogenesis, synaptic plasticity and synaptic transmission. So, its regulatory role in the proliferation, differentiation, and survival of neural progenitor cells in human fetal hippocampus may be partial and stagespecific. Notably, detailed in vitro functional studies on the role and mechanism of action of mGluR5 in neurogenesis in humans are required to corroborate the anatomical observations reported here.
